171 related articles for article (PubMed ID: 6636173)
21. Contribution of acetaminophen-cysteine to acetaminophen nephrotoxicity in CD-1 mice: I. Enhancement of acetaminophen nephrotoxicity by acetaminophen-cysteine.
Stern ST; Bruno MK; Hennig GE; Horton RA; Roberts JC; Cohen SD
Toxicol Appl Pharmacol; 2005 Jan; 202(2):151-9. PubMed ID: 15629190
[TBL] [Abstract][Full Text] [Related]
22. Selective acetaminophen metabolite binding to hepatic and extrahepatic proteins: an in vivo and in vitro analysis.
Bartolone JB; Beierschmitt WP; Birge RB; Hart SG; Wyand S; Cohen SD; Khairallah EA
Toxicol Appl Pharmacol; 1989 Jun; 99(2):240-9. PubMed ID: 2734789
[TBL] [Abstract][Full Text] [Related]
23. Covalent binding of acetaminophen to mouse hemoglobin. Identification of major and minor adducts formed in vivo and implications for the nature of the arylating metabolites.
Axworthy DB; Hoffmann KJ; Streeter AJ; Calleman CJ; Pascoe GA; Baillie TA
Chem Biol Interact; 1988; 68(1-2):99-116. PubMed ID: 3203411
[TBL] [Abstract][Full Text] [Related]
24. Effect of hyperthyroidism on the in vitro metabolism and covalent binding of 1,1-dichloroethylene in rat liver microsomes.
Gunasena GH; Kanz MF
J Toxicol Environ Health; 1997 Oct; 52(2):169-88. PubMed ID: 9310148
[TBL] [Abstract][Full Text] [Related]
25. Metabolism of acetaminophen by the isolated perfused kidney.
Newton JF; Braselton WE; Kuo CH; Kluwe WM; Gemborys MW; Mudge GH; Mudge GH; Hook JB
J Pharmacol Exp Ther; 1982 Apr; 221(1):76-9. PubMed ID: 6278138
[TBL] [Abstract][Full Text] [Related]
26. The nephrotoxicity of p-aminophenol. I. The effect on microsomal cytochromes, glutathione and covalent binding in kidney and liver.
Crowe CA; Yong AC; Calder IC; Ham KN; Tange JD
Chem Biol Interact; 1979 Oct; 27(2-3):235-43. PubMed ID: 115595
[TBL] [Abstract][Full Text] [Related]
27. Nephrotoxicity of 4-aminophenol glutathione conjugate.
Fowler LM; Moore RB; Foster JR; Lock EA
Hum Exp Toxicol; 1991 Nov; 10(6):451-9. PubMed ID: 1687859
[TBL] [Abstract][Full Text] [Related]
28. Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice.
Zaher H; Buters JT; Ward JM; Bruno MK; Lucas AM; Stern ST; Cohen SD; Gonzalez FJ
Toxicol Appl Pharmacol; 1998 Sep; 152(1):193-9. PubMed ID: 9772215
[TBL] [Abstract][Full Text] [Related]
29. Acetaminophen-arylated proteins are detected in hepatic subcellular fractions and numerous extra-hepatic tissues in CD-1 and C57B1/6J mice.
Bulera SJ; Cohen SD; Khairallah EA
Toxicology; 1996 May; 109(2-3):85-99. PubMed ID: 8658549
[TBL] [Abstract][Full Text] [Related]
30. Glutathione conjugation of perchloroethylene in rats and mice in vitro: sex-, species-, and tissue-dependent differences.
Lash LH; Qian W; Putt DA; Desai K; Elfarra AA; Sicuri AR; Parker JC
Toxicol Appl Pharmacol; 1998 May; 150(1):49-57. PubMed ID: 9630452
[TBL] [Abstract][Full Text] [Related]
31. Metabolism and Effects on Endogenous Metabolism of Paracetamol (Acetaminophen) in a Porcine Model of Liver Failure.
Dargue R; Zia R; Lau C; Nicholls AW; Dare TO; Lee K; Jalan R; Coen M; Wilson ID
Toxicol Sci; 2020 May; 175(1):87-97. PubMed ID: 32061126
[TBL] [Abstract][Full Text] [Related]
32. Inhibition by ranitidine of acetaminophen conjugation and its possible role in ranitidine potentiation of acetaminophen-induced hepatotoxicity.
Rogers SA; Gale KC; Newton JF; Dent JG; Leonard TB
J Pharmacol Exp Ther; 1988 Jun; 245(3):887-94. PubMed ID: 3133464
[TBL] [Abstract][Full Text] [Related]
33. Zonation of acetaminophen metabolism and cytochrome P450 2E1-mediated toxicity studied in isolated periportal and perivenous hepatocytes.
Anundi I; Lähteenmäki T; Rundgren M; Moldeus P; Lindros KO
Biochem Pharmacol; 1993 Mar; 45(6):1251-9. PubMed ID: 8466546
[TBL] [Abstract][Full Text] [Related]
34. The effect of propylene glycol on the P450-dependent metabolism of acetaminophen and other chemicals in subcellular fractions of mouse liver.
Snawder JE; Benson RW; Leakey JE; Roberts DW
Life Sci; 1993; 52(2):183-9. PubMed ID: 8355558
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxicity of acetaminophen in human cytochrome P4502E1-transfected HepG2 cells.
Dai Y; Cederbaum AI
J Pharmacol Exp Ther; 1995 Jun; 273(3):1497-505. PubMed ID: 7791125
[TBL] [Abstract][Full Text] [Related]
36. A novel mechanism for the enhancement of acetaminophen hepatotoxicity by phenobarbital.
Douidar SM; Ahmed AE
J Pharmacol Exp Ther; 1987 Feb; 240(2):578-83. PubMed ID: 3806412
[TBL] [Abstract][Full Text] [Related]
37. Hepatotoxicity of acetaminophen in neonatal and young rats. II. Metabolic aspects.
Green MD; Fischer LJ
Toxicol Appl Pharmacol; 1984 Jun; 74(1):125-33. PubMed ID: 6729817
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical localization of acetaminophen in target tissues of the CD-1 mouse: correspondence of covalent binding with toxicity.
Hart SG; Cartun RW; Wyand DS; Khairallah EA; Cohen SD
Fundam Appl Toxicol; 1995 Feb; 24(2):260-74. PubMed ID: 7737437
[TBL] [Abstract][Full Text] [Related]
39. Intrinsic susceptibility of the kidney to acetaminophen toxicity in middle-aged rats.
Tarloff JB; Goldstein RS; Silver AC; Hewitt WR; Hook JB
Toxicol Lett; 1990 Jun; 52(1):101-10. PubMed ID: 2356566
[TBL] [Abstract][Full Text] [Related]
40. Role of pharmacokinetics and metabolism in the enhanced susceptibility of middle-aged male Sprague-Dawley rats to acetaminophen nephrotoxicity.
Tarloff JB; Goldstein RS; Mico BA; Hook JB
Drug Metab Dispos; 1989; 17(2):139-46. PubMed ID: 2565202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
